MoFo News Item

MoFo IP Team Represents Oculeve on Acquisition by Allergan

06 Jul 2015

Global pharmaceutical company Allergan plc, and Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease, have announced an agreement under which Allergan will acquire Oculeve for $125 million as detailed in the press release issued by the companies. 

Morrison & Foerster has been advising Oculeve, Inc. a medical device company located in South San Francisco, CA, since it was founded out of a multi-disciplinary collaboration with the Stanford Biodesign Center and Department of Ophthalmology at Stanford University.

The Morrison & Foerster IP team that represented Oculeve was led by Palo Alto partner Mika Reiner Mayer, associate Amy Rachel Motomura and former associate Marcus Reeslund.

Close

Feedback

Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.